Brown Advisory Inc Neurocrine Biosciences Inc Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Brown Advisory Inc holds 942,147 shares of NBIX stock, worth $135 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

942,147

Previous 995,214 5.33%

Holding current value

$135 Million

Previous $137 Million 20.83%

% of portfolio

0.14%

Previous 0.18%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$114.58 - $153.15 $6.08 Million - $8.13 Million	-53,067 Reduced 5.33%	942,147 $108 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $12.2 Million - $13.3 Million	-93,119 Reduced 8.56%	995,214 $137 Million
Q1 2024 Apr 24, 2024	SELL	$130.4 - $143.74 $3.27 Million - $3.6 Million	-25,080 Reduced 2.25%	1,088,333 $150 Million
Q4 2023 Feb 08, 2024	BUY	$106.07 - $132.76 $2.53 Million - $3.16 Million	23,831 Added 2.19%	1,113,413 $147 Million
Q3 2023 Oct 24, 2023	SELL	$94.02 - $117.1 $965,961 - $1.2 Million	-10,274 Reduced 0.93%	1,089,582 $123 Million
Q2 2023 Jul 31, 2023	BUY	$89.53 - $104.87 $1.88 Million - $2.2 Million	20,963 Added 1.94%	1,099,856 $104 Million
Q1 2023 May 08, 2023	BUY	$94.11 - $123.02 $1.62 Million - $2.12 Million	17,232 Added 1.62%	1,078,893 $109 Million
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $1.42 Million - $1.69 Million	-13,265 Reduced 1.23%	1,061,661 $127 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $473,034 - $554,143	5,140 Added 0.48%	1,074,926 $114 Million
Q2 2022 Nov 14, 2022	BUY	$75.79 - $100.07 $4.63 Million - $6.11 Million	61,036 Added 6.05%	1,069,786 $104 Million
Q2 2022 Sep 13, 2022	BUY	$75.79 - $100.07 $38,728 - $51,135	511 Added 0.05%	1,031,504 $101 Million
Q2 2022 Aug 02, 2022	BUY	$75.79 - $100.07 $4.38 Million - $5.78 Million	57,737 Added 5.93%	1,030,993 $100 Million
Q1 2022 Nov 14, 2022	SELL	$72.45 - $94.81 $1.65 Million - $2.16 Million	-22,754 Reduced 2.21%	1,008,750 $94.6 Million
Q1 2022 Sep 13, 2022	SELL	$72.45 - $94.81 $14,707 - $19,246	-203 Reduced 0.02%	973,256 $91.2 Million
Q1 2022 May 09, 2022	BUY	$72.45 - $94.81 $2.68 Million - $3.51 Million	36,975 Added 3.95%	973,459 $91.2 Million
Q4 2021 Jan 27, 2022	BUY	$79.65 - $106.22 $11.4 Million - $15.2 Million	143,477 Added 18.09%	936,484 $79.8 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $1.26 Million - $1.45 Million	14,661 Added 1.88%	793,007 $76.1 Million
Q2 2021 Jul 29, 2021	BUY	$89.43 - $102.27 $1.24 Million - $1.42 Million	13,887 Added 1.82%	778,346 $75.7 Million
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $5.84 Million - $7.97 Million	66,729 Added 9.56%	764,459 $74.3 Million
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $4.74 Million - $5.91 Million	54,588 Added 8.49%	697,730 $66.9 Million
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $1.7 Million - $2.39 Million	17,707 Added 2.83%	643,142 $61.8 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $1.78 Million - $2.73 Million	20,960 Added 3.47%	625,435 $76.3 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $3.12 Million - $4.72 Million	41,489 Added 7.37%	604,475 $52.3 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $301,456 - $411,793	3,473 Added 0.62%	562,986 $60.5 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $2.12 Million - $2.56 Million	25,268 Added 4.73%	559,513 $50.4 Million
Q2 2019 Aug 12, 2019	BUY	$72.24 - $91.27 $11.5 Million - $14.5 Million	158,858 Added 42.32%	534,245 $45.1 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $4.58 Million - $6.04 Million	66,036 Added 21.35%	375,387 $33.1 Million
Q4 2018 Feb 13, 2019	SELL	$68.32 - $124.36 $312,768 - $569,320	-4,578 Reduced 1.46%	309,351 $22.1 Million
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $1.08 Million - $1.37 Million	10,903 Added 3.6%	313,929 $38.6 Million
Q2 2018 Aug 10, 2018	BUY	$75.3 - $105.99 $1.56 Million - $2.2 Million	20,733 Added 7.34%	303,026 $29.8 Million
Q1 2018 Jun 28, 2018	BUY	$75.88 - $92.43 $9.19 Million - $11.2 Million	121,050 Added 75.07%	282,293 $23.4 Million
Q1 2018 May 14, 2018	SELL	$75.88 - $92.43 $8.81 Million - $10.7 Million	-116,054 Reduced 41.85%	161,243 $13.4 Million
Q4 2017 Feb 12, 2018	BUY	$58.53 - $77.59 $235,583 - $312,299	4,025 Added 1.47%	277,297 $21.5 Million
Q3 2017 Nov 13, 2017	BUY	$47.97 - $61.28 $1.2 Million - $1.54 Million	25,115 Added 10.12%	273,272 $16.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	248,157	248,157 $11.4 Million

Others Institutions Holding NBIX

# of Institutions

632

Shares Held

93.9M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Neurocrine Biosciences Inc Transaction History